Plovanic William J. 4
4 · OBALON THERAPEUTICS INC · Filed Nov 14, 2019
Insider Transaction Report
Form 4
Plovanic William J.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2019-11-12$1.66/sh+65,000$107,822→ 106,806 total
Footnotes (1)
- [F1]The transaction reported on this Form 4 is an open market purchase of Obalon Stock on November 12, 2019 by William Plovanic, totaling $107,822.